tiprankstipranks
Avecho Biotechnology Limited (AU:AVE)
ASX:AVE
Australian Market

Avecho Biotechnology Limited (AVE) Financial Statements

Compare
5 Followers

Avecho Biotechnology Limited Financial Overview

Avecho Biotechnology Limited's market cap is currently AU$22.19M. The company's EPS TTM is AU$-0.001; its P/E ratio is ―; Avecho Biotechnology Limited is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total RevenueAU$ 473.55KAU$ 1.13MAU$ 793.60KAU$ 384.63KAU$ 4.24M
Gross ProfitAU$ -43.80KAU$ 793.12KAU$ -791.78KAU$ -1.72MAU$ 2.39M
Operating IncomeAU$ -4.59MAU$ -3.06MAU$ -4.55MAU$ -3.39MAU$ 587.32K
EBITDAAU$ -3.24MAU$ -2.11MAU$ -2.98MAU$ -2.28MAU$ 1.20M
Net IncomeAU$ -3.44MAU$ -2.34MAU$ -3.42MAU$ -2.63MAU$ 849.96K
Balance Sheet
Cash & Short-Term InvestmentsAU$ 5.50MAU$ 1.47MAU$ 3.26MAU$ 1.87MAU$ 3.21M
Total AssetsAU$ 7.32MAU$ 3.35MAU$ 5.25MAU$ 3.35MAU$ 5.32M
Total DebtAU$ 175.15KAU$ 246.07KAU$ 93.91KAU$ 166.23KAU$ 97.19K
Net DebtAU$ -5.33MAU$ -1.22MAU$ -3.17MAU$ -1.71MAU$ -3.11M
Total LiabilitiesAU$ 941.54KAU$ 920.66KAU$ 709.36KAU$ 700.17KAU$ 556.13K
Stockholders' EquityAU$ 6.38MAU$ 2.42MAU$ 4.54MAU$ 2.65MAU$ 4.76M
Cash Flow
Free Cash FlowAU$ -3.18MAU$ -1.72MAU$ -3.30MAU$ -1.43MAU$ 1.19M
Operating Cash FlowAU$ -3.18MAU$ -1.67MAU$ -3.10MAU$ -1.42MAU$ 1.19M
Investing Cash FlowAU$ 0.00AU$ -53.12KAU$ -202.82KAU$ -5.15KAU$ 11.06K
Financing Cash FlowAU$ 7.22MAU$ -78.22KAU$ 4.69MAU$ -82.50KAU$ -89.44K
Currency in AUD

Avecho Biotechnology Limited Earnings and Revenue History

Avecho Biotechnology Limited Debt to Assets

Avecho Biotechnology Limited Cash Flow

Avecho Biotechnology Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis